New Market Share Record For Mithra Pharmaceuticals In August 2015

Mithra Launches a Capital Increase by Means of a Private Placement via an Accelerated Bookbuild Offering

Liège, Belgium, 21 June 2017 [8.00am CET] – Mithra Pharmaceuticals SA (the ‘Company’ or ‘Mithra’), a company specialized in Women’s Health (Euronext Brussels: MITRA), announces the launch of a capital increase of up to 3,112,975 shares (representing just below 10% of the Company’s shares currently admitted to trading on Euronext Brussels) by means of a private placement via an accelerated bookbuild offering (the ‘Private Placement’).